Health
Maker seeking Indian trial of Novavax jab – McIvor Times
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
General20 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business24 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?
-
General6 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General18 hours agoRobin Williams’s daughter begs fans to stop making AI content of her father